Microlin Bio is an emerging therapeutics company focusing on microRNA and their role in oncology.

Recent News:

February 10, 2016
Microlin Bio Signs Exclusive License and Research Agreement With Université Laval to Develop microRNA-Based Treatments for Alzheimer’s Disease

January 14, 2016
Microlin Bio, Inc. Announces Ticker Symbol Change to MICB